Company Overview
Snapshot
Founded in January 2018 by Maya Ashkenazi (Otmazgin), MAOLAC operates with 11–50 employees. The company has raised $4.05 million across 4 funding rounds from 9 investors. In May 2022, OurCrowd led a Seed funding round for MAOLAC.
Business overview
MAOLAC is a Health Tech & Life Sciences company developing bio-functional proteins (BFPs) for integration into food, beverages, supplements, and cosmetic products. Its core technology, the proprietary Proteomics Discovery Platform (MAOreka), utilizes AI tools like NLP search algorithms and Web Scraping to identify functional protein combinations with high bio-similarity to human breast milk. These functional ingredients, coupled with a unique delivery system, aim to offer enhanced performance for indications such as anti-inflammation and gut health. The company targets the food tech, food processing, and pharma & medical biotechnology sectors, serving global markets with human-grade protein mixtures derived from dairy or plant-based sources.
Strategic signal
In May 2024, MAOLAC received the NutraIngredients Start-up Award 2024, signaling significant industry recognition for its innovative approach to bio-functional proteins. This award validates the company's scientific advancements and market potential within the nutrition and health sectors, suggesting a positive trajectory for product development and commercialization.
Log in to access full profile ›Company Intelligence Q&A
- What is MAOLAC's primary focus?
- MAOLAC focuses on developing novel, high-impact Bio Functional Proteins (BFPs) that can be incorporated into various consumer products, including food, beverages, supplements, and cosmetics.
- What is the MAOreka platform?
- MAOreka is MAOLAC's proprietary Proteomics Discovery Platform. It uses AI tools, including NLP search algorithms and Web Scraping technologies, to identify and enrich specific groups of functional proteins from dairy or plant-based sources that mimic human breast milk.
- When did MAOLAC secure its Seed funding round?
- In May 2022, MAOLAC secured a Seed funding round led by OurCrowd, with participation from theFoodTechLab.
- What was a recent notable achievement for MAOLAC?
- In May 2024, MAOLAC won the NutraIngredients Start-up Award 2024, recognizing its innovative contributions to the industry.
- What is the strategic advantage of MAOLAC's methodology?
- MAOLAC's unique methodology allows for the rapid and cost-effective release of new bioactive products, significantly reducing the typical R&D timeline compared to standard industry processes.